Dr Marie-Paule Richard joins AiCuris as CMO

pharmafile | January 26, 2011 | Appointment | Research and Development |  AiCuris, Dr Marie-Paule Richard, appointment, research and development 

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer.

She has over 24 years of experience in the pharmaceutical industry in a career that has included leading global clinical development projects, supervising clinical-regulatory strategies and managing cross-functional departments.

Marie-Paule spent six years at Bristol-Myers Squibb as a medical-marketing manager, subsequently spending time at Aventis Pharma as European clinical project manager. In 2000, she joined GlaxoSmithKline in the UK as senior director with responsibility for a portfolio of anti-infectives. Thereafter Marie-Paule was appointed VP clinical development in Sanofi Pasteur France.

Advertisement

From 2008, she was a medical advisor for several biotech companies in Switzerland and France, and for a Capital Venture Fund.

Related Content

Charity commits £800,000 to AI research into late breast cancer recurrence

Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

The Gateway to Local Adoption Series

Latest content